Global Neuromonitoring Devices Market Predicted to Exceed $10,276.0 Million, Growing at 7.24% CAGR from 2022 to 2030 [210-Pages] | Research Dive

24 Jun 2022
www.prnewswire.com
Acquisition
Rising advancements neuromonitoring devices by medical device makers is fueling the global neuromonitoring devices market growth. The COVID-19 pandemic has negatively impacted the market. The North America market is likely to dominate the market.
NEW YORK, June 24, 2022 /PRNewswire/ -- Research Dive has added a new report to its offerings titled,
"Neuromonitoring Devices Market by Product (Intracranial Pressure Monitoring, Cerebral Oximeter, Near Infrared Spectroscopy, Speckle Imaging, Doppler Ultrasound, EEG, Fetal/Neonatal Neuromonitoring Devices, Micro Ultrasound, and Others) and Regional Analysis (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2022-2030."
The
global neuromonitoring devices market is expected to garner
$10,276.0 million by 2030, growing at a CAGR of 7.24% from 2022 to 2030. The report delivers comprehensive insights into the current condition and future prospective of the industry by meticulously examining market drivers and restraints, opportunities, major segments, and regions.
Request an Exclusive PDF Sample of the Neuromonitoring Devices Market (Including Tables, TOC & Figures)
Key Segment Findings of the
Market
The market is segmented based on product and region.
The doppler ultrasound sub-segment of the product segment is anticipated to hold highest share of the market and
surpass $3,153.5 million
in the estimated period. This growth is mainly because of the rising cases of neurological disorders amongst people, especially in geriatric population and growing demand for doppler ultrasound due to its efficiency in observing the blood flow through arteries and veins of the patient's body.
Among region, the North America neuromonitoring devices market is projected to observe accelerated
growth and garner $3,534.9 million in the estimated period. The growth of this region market is mostly owing to the growing cases of neurological disorders and rising developments into the neuromonitoring devices' technology by market players in this region.
Break down the Competitive Landscape as per your Requirement & Avail Amazing Discount on Customization
Neuromonitoring Devices Market Dynamics
The key factor fueling the growth of the global neuromonitoring devices market is a significant rise in the neurological disorders like dementia and epilepsy in people, mostly in old-age population, worldwide. In addition, increasing developments and novel product launches by neuromonitoring device manufacturers is expected to open doors to innovative opportunities for the market growth in the projected period. However, huge costs involved in the treatments that include neuromonitoring devices is projected to hinder the market growth during the forecast period.
Impact of the COVID-19 Pandemic on the Neuromonitoring Devices Market:
The outbreak of the COVID-19 pandemic in 2020 has made an adverse impact on the growth of the global neuromonitoring devices market. During the pandemic period, the healthcare sector has observed numerous challenges. Many patients with neurological complaints have postponed their surgeries due to the unavailability of adequate medical facilities and fear of acquiring the deadly COVID-19 virus during hospital visits and treatments. As a result, the demand for neuromonitoring devices has greatly deteriorated, which hindered the market growth during the pandemic period.
Specific Requirements for the Post COVID-19 Impact on Neuromonitoring Devices Market? Get in touch with the Expert Analyst
Top Players of the
Neuromonitoring Devices Market
The major players of the global neuromonitoring devices market are
Intranerve Neuroscience Holdings
Llc
Numerous business strategies, such as acquisitions, mergers, R&D activities, new product developments, and much more, are implemented by these players to attain a strong position in the global market. For instance,
in May 2021, WISE Srl, a medical device firm manufacturing advanced implantable electrodes for neuromonitoring, neuromodulation and brain-machine interfacing (BMI), announced that it's WISE Cortical Strip (WCS), a single use medical equipment which can be used on the brain's surface for intraoperative neurophysiological monitoring (IONM), has obtained CE marking.
Moreover, the report offers other key details of leading players such as business tactics, financial performance, and product/service range of these players along with Porter's five forces analysis and SWOT analysis.
Grab the Full Report here - $2999(Read-Only)
More about Neuromonitoring Devices Market:
Top 3 Intraoperative Neuromonitoring Devices Available in the Market Today
Global Neuromonitoring Devices Market Expected to See Prominent Growth due to the Increasing Demand for Neuromonitoring Devices for Rising Neurological Diseases by 2030
Some related Trending Article Links:
The global x-ray detectors market is predicted to garner $7,426.5 million in the 2021–2028 timeframe: Access to PDF Sample
The global anti-blue ray myopia lenses market is predicted to garner $21,46,138.5 thousand in the 2020–2027 timeframe: Grab an PDF Sample
Bloodstream infection testing market
garnered $4,065.5 million in 2019 and is predicted to generate a revenue of $7,722.2 million by 2027: Request PDF Sample
Research Dive is a market research firm based in Pune, India. Maintaining the integrity and authenticity of the services, the firm provides the services that are solely based on its exclusive data model, compelled by the 360-degree research methodology, which guarantees comprehensive and accurate analysis. With an unprecedented access to several paid data resources, team of expert researchers, and strict work ethic, the firm offers insights that are extremely precise and reliable. Scrutinizing relevant news releases, government publications, decades of trade data, and technical & white papers, Research dive deliver the required services to its clients well within the required timeframe. Its expertise is focused on examining niche markets, targeting its major driving factors, and spotting threatening hindrances. Complementarily, it also has a seamless collaboration with the major industry aficionado that further offers its research an edge.
Contact:
Mr. Abhishek Paliwal
30 Wall St. 8th Floor, New York NY 10005
(P) +91-(788)-802-9103 (India)
+1-(917)-444-1262 (US)
Toll Free: 1-888-961-4454
E-mail: [email protected]
Website:
https://www.researchdive.com
Blog:
https://www.researchdive.com/blog/
LinkedIn:
https://www.linkedin.com/company/research-dive/
Twitter:
https://twitter.com/ResearchDive
https://www.facebook.com/Research-Dive-138554231492752
SOURCE Research Dive
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.